These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 19328963

  • 1. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 2. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
    Elaerts S, Olejnik Y, Bonardet A, Garrigue V, Mourad G, Cristol JP, Dupuy AM.
    Transplant Proc; 2005 Mar; 37(1):167-71. PubMed ID: 15808583
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients.
    Huet E, Morand K, Blanchet B, Astier A, Hulin A.
    Transplant Proc; 2004 Jun; 36(5):1317-20. PubMed ID: 15251322
    [Abstract] [Full Text] [Related]

  • 4. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R.
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [Abstract] [Full Text] [Related]

  • 5. Preliminary evaluation of a new chemiluminescence assay (Liaison Cyclosporine; DiaSorin Laboratories) allowing both C0 and C2 cyclosporine levels determination: comparison with RIA method.
    Olejnik Y, Elaerts S, Bonardet A, Chong G, Mourad G, Cristol JP, Dupuy AM.
    Transplant Proc; 2005 Oct; 37(1):172-4. PubMed ID: 15808584
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of C0 and C2 blood concentrations of cyclosporine on the Roche Hitachi 902 analyzer.
    Yargui L, Berhoune A.
    Transplant Proc; 2009 Nov 01; 41(9):3713-9. PubMed ID: 19917373
    [Abstract] [Full Text] [Related]

  • 8. Correlation of C0 and C2 levels with cyclosporine side effects in kidney transplantation.
    Rodrigo E, Ruiz JC, Angeles de Cos M, Ruiz J, Gago M, Piñera C, Sánchez B, González-Cotorruelo J, Gómez-Alamillo C, Arias M.
    Transplant Proc; 2009 Nov 01; 41(6):2328-31. PubMed ID: 19715910
    [Abstract] [Full Text] [Related]

  • 9. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T, Takeuchi H, Nakamura Y, Konno O, Yokoyama T, Iwamoto H, Hama K, Hirano T, Unezaki S, Okuyama K, Shimazu M.
    Transplant Proc; 2012 Jan 01; 44(1):134-6. PubMed ID: 22310597
    [Abstract] [Full Text] [Related]

  • 10. Suitable whole blood levels 2 hours after neoral in liver transplant patients: experiences at a single center.
    Kim KH, Lee SG, Lee YJ, Park KM, Hwang S, Ahn CS, Moon DB, Ha TY, Song KW, Kim DS, Jung DH, Kim BS, Moon KM, Lee HJ, Park JI, Ryu JH.
    Transplant Proc; 2006 Nov 01; 38(9):2971-3. PubMed ID: 17112877
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M.
    Transplant Proc; 2004 Nov 01; 36(1):86-8. PubMed ID: 15013308
    [Abstract] [Full Text] [Related]

  • 12. History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion.
    Cantarovich M, Barkun J, Giannetti N, Cecere R, Besner JG, Tchervenkov J.
    Transplant Proc; 2004 Mar 01; 36(2 Suppl):442S-447S. PubMed ID: 15041383
    [Abstract] [Full Text] [Related]

  • 13. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK, Chang HK, Kim HJ, Huh KH, Ahn HJ, Kim MS, Kim SI, Kim YS.
    Transplant Proc; 2008 Dec 01; 40(10):3673-8. PubMed ID: 19100463
    [Abstract] [Full Text] [Related]

  • 14. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer.
    Griffey MA, Hock KG, Kilgore DC, Wei TQ, Duh SH, Christenson R, Scott MG.
    Clin Chim Acta; 2007 Sep 01; 384(1-2):48-51. PubMed ID: 17588555
    [Abstract] [Full Text] [Related]

  • 15. Automated monitoring of C2 and C0 blood levels of mycophenolic acid and cyclosporine on the Abbott Architect c8000.
    Boer K, Brehmer-Streck S, Deufel T, Schmidt D, Kiehntopf M.
    Clin Biochem; 2007 Oct 01; 40(15):1163-7. PubMed ID: 17689516
    [Abstract] [Full Text] [Related]

  • 16. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Liver Transpl; 2008 Feb 01; 14(2):173-80. PubMed ID: 18236391
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L.
    Transplant Proc; 2006 Feb 01; 38(1):94-6. PubMed ID: 16504673
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of the heterogeneous immunoassay (ACMIA) for the measurement of blood cyclosporin on the Behring dimension RXL clinical chemistry analyzer].
    Morand K, Huet E, Blanchet B, Astier A, Hulin A.
    Ann Biol Clin (Paris); 2003 Feb 01; 61(6):713-8. PubMed ID: 14711615
    [Abstract] [Full Text] [Related]

  • 19. C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients.
    Caforio AL, Tona F, Piaserico S, Gambino A, Feltrin G, Fortina AB, Angelini A, Alaibac M, Bontorin M, Calzolari D, Peserico A, Thiene G, Iliceto S, Gerosa G.
    Transpl Int; 2005 Jan 01; 18(1):116-24. PubMed ID: 15612993
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
    Koefoed-Nielsen PB, Karamperis N, Jørgensen KA.
    Transplant Proc; 2005 May 01; 37(4):1736-8. PubMed ID: 15919449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.